SHIPPEO
7.12.2022 11:55:36 CET | Business Wire | Press release
Shippeo, a leading provider of global and multimodal shipment visibility, announced major platform enhancements as part of their feature-packed 2022 Autumn platform release at their Visibility Now! event in Paris. The update brings a range of new, disruptive capabilities to their Ocean Visibility solution, higher accuracy carbon emissions calculations powered by specialist Searoutes, and a range of general enhancements aimed at boosting data quality, usability and supply chain ecosystem collaboration.
“We know that supply chain resiliency is top of mind for supply chain executives and that dynamic operational visibility is foundational for resilience,” explains Anand Medepalli, Chief Product Officer at Shippeo. “Our latest platform release brings a range of exciting features and capabilities, arming organizations with the tools and knowledge to make quicker decisions, mitigate disruptions and collaborate with trading partners in real time, so that supply chain actors can design, plan and run the most profitable, sustainable and resilient supply chains.”
“The enormous challenges and uncertainty around ocean shipping, and growing internal and external pressures for businesses to operate more sustainably, are key drivers for the exciting innovations we’re introducing in our Autumn release, delivering significant value for our customers. We know that Shippeo’s value comes from us being a reliable visibility platform with a strong carrier network delivering high quality visibility data and meaningful insights with an intuitive user experience. These are precisely the areas our product team focused on in 2022.”
Major enhancements to Ocean Visibility platform including a new Port Insights engine
Shippeo’s latest Ocean Visibility solution updates provide customers with more useful, higher-quality ocean transport data, thanks to a new tech architecture supporting data quality and scalability improvements, making it possible to track an unlimited number of containers across multiple data sources. In addition, new dashboards provide powerful insights to aid in contract negotiations with carriers.
Enhanced demurrage and detention analytics down to a port pair level make it easier to identify and proactively react to affected containers. New Lane Insights highlight lead time, punctuality, transshipment duration, and more, offering new network analysis tools for shippers. Shippers can identify weak spots, such as ports or carriers experiencing frequent delays, and access lane analysis for specific routes.
Port Insights provides shippers with a better understanding of congestion and efficiency at ports throughout the world. In addition, by drawing on Shippeo’s multi-year research into ETA algorithms and geofencing technology, users benefit from best-in-class vessel ETAs, promising significant accuracy improvements over those provided by shipping lines. Through combining historical data with live AIS satellite data, terrestrial data and vessel schedule data, Shippeo’s Port Insights engine generates more accurate arrival and departure events at marine ports, resulting in the highest fidelity visibility of journeys and milestones for any shipment.
“We believe our Ocean Visibility platform offers the most accurate view available of what’s happening for any port on the planet,” says Medepalli. “With insights on more than 3000 ports worldwide, we offer customers a more complete and accurate understanding of their vessel routes. Along with our enhanced Demurrage and Detention dashboard, Lane Insights and best-in-class vessel ETA algorithm, our latest ocean product update is a disruptive, market-leading solution. And, as it is built on the same platform as our Road, Air and Rail Visibility solutions, we can help track multimodal shipments, regardless of which modes are used.”
New Searoutes partnership for reliable, global CO2 emission calculations
Shippeo’s Carbon Visibility product takes granular shipment level data, including routes, mileage, and more, to estimate carbon emissions attributable to road, ocean, inland waterway, rail and air shipments. A new platform integration with specialist carbon emissions estimating company Searoutes now allows accredited, higher quality carbon, and other greenhouse gas-equivalent emissions calculations across all transport modes in a single platform.
Searoutes also offers the unique benefit of modeled calculations for both milk-runs over road, and for ocean shipments. Advanced algorithms and a more detailed analysis, mean emissions are now less likely to be overstated and insights are more actionable.
“By combining Shippeo’s high quality data and Searoutes’s state-of-the-art models, our platform offers a unique and powerful Carbon Visibility solution to help our customers run sustainable supply chains,” explains Medepalli. “Our approach to carbon reporting simplifies effort for shippers and carriers by combining analysis across all modes in a single platform, and makes it possible to review carbon footprint at different levels of granularity, such as by region or business unit.”
Searoutes CEO, Pierre Garreau, expresses his delight about the partnership. “Searoutes was founded to find ways to use the latest data modeling and AI to solve the dual challenge of lowering fuel consumption and carbon emissions in one of the biggest contributing sectors to climate change; transportation,” says Garreau. “Today, Shippeo offers the best visibility data stewardship out there, so the mix of their excellent data quality with top-notch greenhouse gas emissions modeling from Searoutes will give customers the ability to have extremely accurate emissions reporting to help figure out a baseline for determining the best supply chain strategy, as they navigate an increasingly regulated shipping landscape.”
Platform innovations boosting data quality, usability and supply chain ecosystem collaboration
Along with Ocean and Carbon Visibility solution enhancements, Shippeo has introduced a number of other platform updates to propel its category-leading data intelligence capabilities even further. It’s now easier to detect broken telematics units with Shippeo platform’s unique Smart Tracking Analyzer, a tool which analyzes root-causes of low tracking rates and prescribes actions for users to remedy them. In addition, it’s now possible for users to update transport orders and add milestone events, such as multiple delivery attempts, even after transportation has finished, so that recorded information can be made more accurate, contributing to overall quality of visibility data.
In parallel, a new Notifications Builder offers platform users the ability to fully configure, customize and white label notifications. With a simple UI, the tool introduces greater flexibility for new ways to communicate and collaborate with ecosystem partners.
Watch Shippeo’s full autumn platform release announcement
About Searoutes
Searoutes specializes in innovative digital solutions for sustainability within the sea, air and logistics sector. The company is rooted in its proprietary routing algorithms that use historical ship data collected from AIS signals that allow for greater accuracy through superior methodologies. Today, Searoutes has developed a comprehensive collection of APIs to search, report and plan on real-time routes and CO2 emissions for all modes of transport to facilitate the decarbonization of freight transport.
About Shippeo
Shippeo is a global leader in real-time multimodal transportation visibility, helping major shippers and logistics service providers operate more collaborative, automated, sustainable, profitable, and customer-centric supply chains. This is made possible with highly accurate, real-time operational visibility and perfect workflow orchestration. Their Multimodal Visibility Network integrates with more than 875 TMS, telematics and ELD systems, enabling Shippeo’s platform to provide instant access to real-time shipment tracking across all transport modes, in a single portal, through an intuitive user experience. A proprietary and industry-leading machine learning algorithm offers unmatched ETA accuracy, allowing supply chain companies to quickly anticipate problems, proactively alert customers, efficiently manage exceptions with collaborative workflows, and accurately measure CO2 and GHG emissions from supply chain transport. Hundreds of customers, including global brands like Coca-Cola HBC, Carrefour, Renault Group, Schneider Electric, Total, Siemens Energy, Faurecia, Saint-Gobain and Eckes Granini, trust Shippeo to track more than 28 million shipments per year across 95 countries. Learn more at www.shippeo.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221206005768/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NTT DOCOMO BUSINESS and Chile’s State-owned Copper Company CODELCO Launch a Study and Proof of Concept Aimed at Improving the Efficiency of Remote Copper Mine Operations Using IOWN® APN6.8.2026 06:30:00 CEST | Press release
NTT DOCOMO BUSINESS, Inc. (formerly NTT Communications Corporation) has launched a study and proof of concept jointly with Corporación Nacional del Cobre de Chile (CODELCO) to progress remote operations at CODELCO’s copper mines using an IOWN® All-Photonics Network (APN).1 This initiative is part of a research project commissioned by Japan’s Ministry of Internal Affairs and Communications.2 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806845222/en/ Conceptual Diagram of the Demonstration To address operational challenges faced by CODELCO’s copper mines, the initiative will connect a copper mine and a remote operations center—approximately 1,500 km apart—via an IOWN APN. It will assess the feasibility of remotely operating heavy machinery using high-capacity, low-latency communication links, enhancing monitoring operations through high-definition video, and implementing a remote operations model. 1. Background Chile is o
FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release
Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release
Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release
Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
